Management of depressive symptoms in schizophrenia: a pooled, post hoc analysis from the asenapine development program

被引:0
|
作者
Castle, D. [1 ]
Jensen, J. K. S. [2 ]
机构
[1] Univ Western Australia, Melbourne, Vic, Australia
[2] H Lundbeck & Co AS, Dept Biostat, Valby, Denmark
关键词
D O I
10.1016/S0924-977X(13)70797-1
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
P.3.f.019
引用
收藏
页码:S502 / S503
页数:2
相关论文
共 50 条
  • [31] Cariprazine for negative symptoms of schizophrenia: pooled post hoc analysis of 2 randomized, double-blind, placebo- and active-controlled trials
    Durgam, S.
    Earley, W.
    Lu, K.
    Nemeth, G.
    Laszlovszky, I.
    Szatmari, B.
    Edwards, J.
    Nasrallah, H. A.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2016, 26 : S552 - S552
  • [32] Association between fatigue and depressive symptoms in persons with post-COVID-19 condition: a post hoc analysis
    Teopiz, Kayla M.
    Kwan, Angela T. H.
    Le, Gia Han
    Guo, Ziji
    Badulescu, Sebastian
    Ceban, Felicia
    Meshkat, Shakila
    Di Vincenzo, Joshua D.
    d'Andrea, Giacomo
    Cao, Bing
    Ho, Roger
    Rhee, Taeho Greg
    Dev, Donovan A.
    Phan, Lee
    Subramaniapillai, Mehala
    Mansur, Rodrigo B.
    Rosenblat, Joshua D.
    Mcintyre, Roger S.
    CURRENT MEDICAL RESEARCH AND OPINION, 2024, 40 (07) : 1203 - 1209
  • [33] Effect of safinamide in depressive symptoms: a post-hoc analysis of SADNESS-PD study
    Pena, E.
    Borrue, C.
    Mata Alvarez-Santullano, M.
    Ruiz Huete, C.
    Martinez Castrillo, J.
    Alonso Canovas, A.
    Chico, J.
    Lopez Manzanares, L.
    Llanero Luque, M.
    Herreros Rodriguez, J.
    Esquivel, A.
    Maycas, T.
    EUROPEAN JOURNAL OF NEUROLOGY, 2021, 28 : 838 - 838
  • [34] Efficacy of Adjunctive Cariprazine in Patients With Major Depressive Disorder and Anxiety Symptoms: A Post Hoc Analysis
    Fava, Maurizio
    Maletic, Vladimir
    Chen, Chen
    Adams, Julie
    Kramer, Ken
    Kerolous, Majid
    NEUROPSYCHOPHARMACOLOGY, 2022, 47 : 260 - 261
  • [35] Efficacy of Adjunctive Cariprazine in Patients With Major Depressive Disorder and Anxiety Symptoms: A Post Hoc Analysis
    Fava, Maurizio
    Maletic, Vladimir
    Chen, Chen
    Adams, Julie
    Kramer, Ken
    Kerolous, Majid
    NEUROPSYCHOPHARMACOLOGY, 2022, 47 (SUPPL 1) : 260 - 261
  • [36] Depressive Symptoms in a Trial Behavioral Family Systems Therapy for Diabetes: A Post Hoc Analysis of Change
    Riley, Andrew R.
    Duke, Danny C.
    Freeman, Kurt A.
    Hood, Korey K.
    Harris, Michael A.
    DIABETES CARE, 2015, 38 (08) : 1435 - 1440
  • [37] Cariprazine vs risperidone efficacy on predominant negative symptoms of schizophrenia: post hoc analysis of negative symptoms subdomains
    Laszlovszky, I.
    Barabassy, A.
    Szatmari, B.
    Harsanyi, J.
    Szalai, E.
    Nemeth, G.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2017, 27 : S902 - S903
  • [38] LURASIDONE IN THE TREATMENT OF EARLY-STAGE SCHIZOPHRENIA: A POST HOC ANALYSIS OF THREE POOLED ACUTE TREATMENT STUDIES
    Lieberman, J. A.
    Pikalov, A.
    Hsu, J.
    Cucchiaro, J.
    Werner, P.
    Grossman, F.
    Loebel, A.
    EUROPEAN PSYCHIATRY, 2013, 28
  • [39] The Acute Efficacy of Aripiprazole Across the Symptom Spectrum of Schizophrenia: A Pooled Post Hoc Analysis From 5 Short-Term Studies
    Janicak, Philip G.
    Glick, Ira D.
    Marder, Stephen R.
    Crandall, David T.
    McQuade, Robert D.
    Marcus, Ronald N.
    Eudicone, James M.
    Assuncao-Talbott, Sheila
    JOURNAL OF CLINICAL PSYCHIATRY, 2009, 70 (01) : 25 - 35
  • [40] MP-AzeFlu for management of allergic rhinitis symptoms in patients ≥65 years: A post hoc efficacy and safety analysis from three pooled phase 3 trials
    Bousquet, J.
    Meltzer, E. O.
    Kuhl, H.
    Koltun, A.
    Kopietz, F.
    Munzel, U.
    ALLERGY, 2018, 73 : 573 - 574